Liu [13] demonstrated that treatment with the gene delivery technique resulting in in vivo expression of a recombinant CBD-HepII bifunctional-domain polypeptide of FN, designated as CH50, inhibited tumor metastasis to the liver. The gene discussed is FN1; the disease is neoplasm.